Yanjun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yanjun Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Liang Sang
Department of Ultrasound, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China
5 shared publications- Zhiguang Chen
Department of Ultrasound, The First Hospital of China Medical University, Shenyang, China
5 shared publications Xingzhe Li
Department of Ultrasound, The First Hospital of China Medical University, Shenyang, China
3 shared publications- ZhiQun Bai
Department of Ultrasound, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China
3 shared publications Ziyao Ji
Department of Ultrasound, The First Hospital of China Medical University, Shenyang, China
3 shared publicationsJiaxin Zhang
Department of Ultrasound, The First Hospital of China Medical University, Shenyang, China
2 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by Springer Nature in Cancer Imaging
- Vol. 26 (1)
Contrast-enhanced ultrasound quantitative parameters for predicting benign and malignant greater omentum lesions: an applied study
To explore the value of contrast-enhanced ultrasound (CEUS) quantitative parameters in differentiating benign and malignant diseases of the greater omentum
- 2 January 2026
- Published by Springer Nature in Cancer Imaging
- Vol. 26 (1)
Open AccessContrast-enhanced ultrasound quantitative parameters for predicting benign and malignant greater omentum lesions: an applied study
To explore the value of contrast-enhanced ultrasound (CEUS) quantitative parameters in differentiating benign and malignant diseases of the greater omentum
- Open Access
- 24 October 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (11) , 1378
A Review on the Structure-Response-Efficacy Optimization of Ultrasound-Responsive Micro/Nanobubbles for Cancer Therapy
Ultrasound-responsive micro/nanobubbles (MNBs) are promising tools for targeted cancer therapy due to their controllable acoustic activation and real-time imaging. Despite extensive research, the quantitative relationship between bubble structure, acoustic response, and therapeutic efficacy remains poorly understood. This knowledge gap hinders parametric design and clinical standardization. This review summarizes recent advances from an engineering perspective, highlighting how structural parameters—such as size, shell, gas core, and ligand density—affect acoustic sensitivity and drug release. Furthermore, the roles of microfluidic electroporation and cell membrane coating are discussed in terms of controllable fabrication and preservation of biological functions, highlighting their significance for reproducible and predictable therapies. In conclusion, this review establishes a “Structure-Response-Efficacy (S-R-E)” framework to summarize the core relationships between structural design and acoustic modulation. We propose an engineering strategy based on a standardized parameter system to guide the predictable design and clinical translation of ultrasound-based theranostic platforms.
- 24 October 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (11) , 1378
Open AccessA Review on the Structure-Response-Efficacy Optimization of Ultrasound-Responsive Micro/Nanobubbles for Cancer Therapy
Ultrasound-responsive micro/nanobubbles (MNBs) are promising tools for targeted cancer therapy due to their controllable acoustic activation and real-time imaging. Despite extensive research, the quantitative relationship between bubble structure, acoustic response, and therapeutic efficacy remains poorly understood. This knowledge gap hinders parametric design and clinical standardization. This review summarizes recent advances from an engineering perspective, highlighting how structural parameters—such as size, shell, gas core, and ligand density—affect acoustic sensitivity and drug release. Furthermore, the roles of microfluidic electroporation and cell membrane coating are discussed in terms of controllable fabrication and preservation of biological functions, highlighting their significance for reproducible and predictable therapies. In conclusion, this review establishes a “Structure-Response-Efficacy (S-R-E)” framework to summarize the core relationships between structural design and acoustic modulation. We propose an engineering strategy based on a standardized parameter system to guide the predictable design and clinical translation of ultrasound-based theranostic platforms.
- Open Access
- 9 May 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (13) , 6236-6252
Piezo-catalytic immunotherapy: mechanisms and feasibility in cancer treatment
Over the past decade, immunotherapy has revolutionized the clinical management of numerous cancer types. However, only a subset of patients derives long-term durable tumor control from it. Intriguingly, several emerging therapeutic strategies harnessing reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) hold promise for enabling precision immunotherapy in cancer, with sonodynamic therapy emerging as a notable example. The utilization of piezoelectric materials as sonosensitizers can effectively enhance ROS production, thereby augmenting the efficacy of ICD-induced immunotherapy. Additionally, electrical stimulation generated by the piezoelectric effect can further induce immune response activation and necroptosis, achieving a synergistic effect in piezo-catalytic immunotherapy. Herein, we will systematically review the pathways and potential mechanisms underlying piezo-catalytic immunotherapy, offering novel insights for the exploration of cancer immunotherapy strategies.
- 9 May 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (13) , 6236-6252
Open AccessPiezo-catalytic immunotherapy: mechanisms and feasibility in cancer treatment
Over the past decade, immunotherapy has revolutionized the clinical management of numerous cancer types. However, only a subset of patients derives long-term durable tumor control from it. Intriguingly, several emerging therapeutic strategies harnessing reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) hold promise for enabling precision immunotherapy in cancer, with sonodynamic therapy emerging as a notable example. The utilization of piezoelectric materials as sonosensitizers can effectively enhance ROS production, thereby augmenting the efficacy of ICD-induced immunotherapy. Additionally, electrical stimulation generated by the piezoelectric effect can further induce immune response activation and necroptosis, achieving a synergistic effect in piezo-catalytic immunotherapy. Herein, we will systematically review the pathways and potential mechanisms underlying piezo-catalytic immunotherapy, offering novel insights for the exploration of cancer immunotherapy strategies.
- Open Access
- 19 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Identification and validation of a novel machine learning model for predicting severe pelvic endometriosis: A retrospective study
This study aimed to explore potential risk factors for severe endometriosis and to develop a model to predict the risk of severe endometriosis. A total of 308 patients with endometriosis were analyzed. Least absolute shrinkage and selection operator (LASSO) was performed to identify the potential risk factors for severe endometriosis. Then, we used seven machine learning (ML) algorithms to construct the predictive models. Finally, SHapley Additive exPlanations (SHAP) interpretation was performed to evaluate the contributions of each factor to risk prediction. About 59.2% (183/308) of patients were diagnosed with severe endometriosis. The random forest (RF) model performed best in discriminative ability among the seven ML models, achieving an area under the curve (AUC) of 0.744. After reducing features according to feature importance rank, an explainable final RF model was established with six features. From the SHAP map, we found that the negative sliding sign had the greatest impact on the diagnostic performance of the RF model. This study provided a personalized risk assessment for the development of severe endometriosis, which may enable early identification of high-risk patients, facilitating timely intervention and optimized treatment strategies.
- 19 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessIdentification and validation of a novel machine learning model for predicting severe pelvic endometriosis: A retrospective study
This study aimed to explore potential risk factors for severe endometriosis and to develop a model to predict the risk of severe endometriosis. A total of 308 patients with endometriosis were analyzed. Least absolute shrinkage and selection operator (LASSO) was performed to identify the potential risk factors for severe endometriosis. Then, we used seven machine learning (ML) algorithms to construct the predictive models. Finally, SHapley Additive exPlanations (SHAP) interpretation was performed to evaluate the contributions of each factor to risk prediction. About 59.2% (183/308) of patients were diagnosed with severe endometriosis. The random forest (RF) model performed best in discriminative ability among the seven ML models, achieving an area under the curve (AUC) of 0.744. After reducing features according to feature importance rank, an explainable final RF model was established with six features. From the SHAP map, we found that the negative sliding sign had the greatest impact on the diagnostic performance of the RF model. This study provided a personalized risk assessment for the development of severe endometriosis, which may enable early identification of high-risk patients, facilitating timely intervention and optimized treatment strategies.
- 27 March 2025
- Published by Springer Nature in European Radiology
- Vol. 35 (9) , 5457-5467
Safety and efficacy evaluation of contrast-enhanced ultrasound-guided omental biopsy: a single-center prospective study
Objectives Contrast-enhanced ultrasound (CEUS) assesses omental lesion nature, but CEUS-guided biopsy feasibility, effectiveness, and safety are uncertain. Methods From January 2020 to January 2024, patients scheduled for ultrasound-guided omental biopsy at the First Hospital of China Medical University were enrolled. They were divided into CEUS-guided and conventional ultrasound-guided groups, balanced using propensity score matching (PSM). Success rate, diagnostic accuracy, and complication rate were compared. Subgroup analyses considered sonographic features, with significance at p < 0.05. Results After PSM, 310 CEUS-guided and 160 conventional ultrasound-guided patients were analyzed. Groups were similar in demographics and omental characteristics (p > 0.05). CEUS-guided biopsy had higher sample acquisition (97.42% vs. 93.13%, p = 0.029) and diagnostic accuracy (96.03% vs. 87.92%, p = 0.002). Overall complication rate was 9.36% (44/470), with distant metastasis in 0.43% (2/470). Complication rates did not differ significantly between groups. In hyperechoic group, dense group, and non-nodule group, CEUS-guided biopsy had higher success (97.99% vs. 92.55%, p = 0.042) and accuracy (96.48% vs. 86.17%, p = 0.002). In non-nodule group, CEUS-guided accuracy was superior (93.41% vs. 84.11%, p = 0.015). Conclusion Ultrasound-guided omental biopsy is a safe and effective method for obtaining samples. CEUS-guided omental biopsy enhances sample acquisition and diagnostic accuracy, especially in hyperechoic group, dense group, and non-nodule group, suggesting it is a more accurate and effective diagnostic method. Key Points Question Selecting a puncture site for diffuse lesions of the greater omentum presents challenges, as conventional ultrasound-guided biopsy often encounters difficulties in avoiding local necrotic tissue. Findings Ultrasound-guided biopsy of the greater omentum is a safe and effective diagnostic method, especially when augmented with CEUS, which can significantly enhance diagnostic accuracy. Clinical relevance CEUS can markedly enhance diagnostic accuracy by providing a robust foundation for selecting the biopsy site and pathway. Therefore, it is advisable to routinely employ CEUS-guided puncture pathways for atypical omental lesions. Graphical Abstract
- 27 March 2025
- Published by Springer Nature in European Radiology
- Vol. 35 (9) , 5457-5467
Safety and efficacy evaluation of contrast-enhanced ultrasound-guided omental biopsy: a single-center prospective study
Objectives Contrast-enhanced ultrasound (CEUS) assesses omental lesion nature, but CEUS-guided biopsy feasibility, effectiveness, and safety are uncertain. Methods From January 2020 to January 2024, patients scheduled for ultrasound-guided omental biopsy at the First Hospital of China Medical University were enrolled. They were divided into CEUS-guided and conventional ultrasound-guided groups, balanced using propensity score matching (PSM). Success rate, diagnostic accuracy, and complication rate were compared. Subgroup analyses considered sonographic features, with significance at p < 0.05. Results After PSM, 310 CEUS-guided and 160 conventional ultrasound-guided patients were analyzed. Groups were similar in demographics and omental characteristics (p > 0.05). CEUS-guided biopsy had higher sample acquisition (97.42% vs. 93.13%, p = 0.029) and diagnostic accuracy (96.03% vs. 87.92%, p = 0.002). Overall complication rate was 9.36% (44/470), with distant metastasis in 0.43% (2/470). Complication rates did not differ significantly between groups. In hyperechoic group, dense group, and non-nodule group, CEUS-guided biopsy had higher success (97.99% vs. 92.55%, p = 0.042) and accuracy (96.48% vs. 86.17%, p = 0.002). In non-nodule group, CEUS-guided accuracy was superior (93.41% vs. 84.11%, p = 0.015). Conclusion Ultrasound-guided omental biopsy is a safe and effective method for obtaining samples. CEUS-guided omental biopsy enhances sample acquisition and diagnostic accuracy, especially in hyperechoic group, dense group, and non-nodule group, suggesting it is a more accurate and effective diagnostic method. Key Points Question Selecting a puncture site for diffuse lesions of the greater omentum presents challenges, as conventional ultrasound-guided biopsy often encounters difficulties in avoiding local necrotic tissue. Findings Ultrasound-guided biopsy of the greater omentum is a safe and effective diagnostic method, especially when augmented with CEUS, which can significantly enhance diagnostic accuracy. Clinical relevance CEUS can markedly enhance diagnostic accuracy by providing a robust foundation for selecting the biopsy site and pathway. Therefore, it is advisable to routinely employ CEUS-guided puncture pathways for atypical omental lesions. Graphical Abstract
- Open Access
- 17 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101661
Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors
- 17 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101661
Open AccessUltrasound-responsive nanoparticles for imaging and therapy of brain tumors
- Open Access
- 10 March 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 28
Innovative optimization of greater omentum imaging report and data system for enhanced risk stratification of omental lesions
Background: In 2020, we introduced the Greater Omentum Imaging-Reporting and Data System (GOI-RADS), a novel classification system related to peritoneal lesions. However, its clinical application remained unvalidated. Objective: This study aimed to validate GOI-RADS, optimize its parameters for a new grading system, and explore its clinical usefulness. Methods: A retrospective-prospective study was conducted to validate and refine the GOI-RADS system. The study consisted of two phases: a retrospective validation phase and a prospective application phase. The first phase included patients with peritoneal lesions from 2019 to 2021, classified by GOI-RADS and verified against pathology. Contrast-enhanced ultrasound (CEUS) and real-time elastography (RTE) data were collected for developing a new grading system. Odds ratios optimized parameters. The second phase (2021–2024) assessed diagnostic consistency among sonographers and performance of grading systems. Results: Among 215 patients with peritoneal lesions, the actual malignancy rates for GOI-RADS 2 (40.00%) and GOI-RADS 3 (61.22%) were much higher than predicted (5.56% and 37.25%). Combining CEUS and RTE parameters showed varying sensitivity and specificity: RTE + GOI-RADS (95.35%, 55.56%) and CEUS + GOI-RADS (96.51%, 44.44%). However, the grading system based on multiple ultrasound parameters, specifically when incorporating RTE, CEUS parameters, and GOI-RADS (Multi-GOIRADS), exhibited the highest diagnostic sensitivity and specificity of 88.37% and 83.33%, respectively. Its simplified version, sMulti-GOIRADS, had sensitivity of 73.26% and specificity of 94.44%. In the prospective study involving three sonographers of different qualifications, the use of sMulti-GOIRADS was found to be the most time-efficient and showed excellent diagnostic consistency among them. In contrast, Multi-GOIRADS required more time for scoring but offered superior diagnostic performance, particularly among senior sonographers (88.35% and 91.43%). Conclusions: This study proposes a multiparametric ultrasound-based imaging-reporting and data system for risk stratification of omental malignancy, Multi-GOIRADS, and presents an optimized and simplified version, sMulti-GOIRADS, which demonstrates excellent diagnostic consistency and performance in clinical applications.
- 10 March 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 28
Open AccessInnovative optimization of greater omentum imaging report and data system for enhanced risk stratification of omental lesions
Background: In 2020, we introduced the Greater Omentum Imaging-Reporting and Data System (GOI-RADS), a novel classification system related to peritoneal lesions. However, its clinical application remained unvalidated. Objective: This study aimed to validate GOI-RADS, optimize its parameters for a new grading system, and explore its clinical usefulness. Methods: A retrospective-prospective study was conducted to validate and refine the GOI-RADS system. The study consisted of two phases: a retrospective validation phase and a prospective application phase. The first phase included patients with peritoneal lesions from 2019 to 2021, classified by GOI-RADS and verified against pathology. Contrast-enhanced ultrasound (CEUS) and real-time elastography (RTE) data were collected for developing a new grading system. Odds ratios optimized parameters. The second phase (2021–2024) assessed diagnostic consistency among sonographers and performance of grading systems. Results: Among 215 patients with peritoneal lesions, the actual malignancy rates for GOI-RADS 2 (40.00%) and GOI-RADS 3 (61.22%) were much higher than predicted (5.56% and 37.25%). Combining CEUS and RTE parameters showed varying sensitivity and specificity: RTE + GOI-RADS (95.35%, 55.56%) and CEUS + GOI-RADS (96.51%, 44.44%). However, the grading system based on multiple ultrasound parameters, specifically when incorporating RTE, CEUS parameters, and GOI-RADS (Multi-GOIRADS), exhibited the highest diagnostic sensitivity and specificity of 88.37% and 83.33%, respectively. Its simplified version, sMulti-GOIRADS, had sensitivity of 73.26% and specificity of 94.44%. In the prospective study involving three sonographers of different qualifications, the use of sMulti-GOIRADS was found to be the most time-efficient and showed excellent diagnostic consistency among them. In contrast, Multi-GOIRADS required more time for scoring but offered superior diagnostic performance, particularly among senior sonographers (88.35% and 91.43%). Conclusions: This study proposes a multiparametric ultrasound-based imaging-reporting and data system for risk stratification of omental malignancy, Multi-GOIRADS, and presents an optimized and simplified version, sMulti-GOIRADS, which demonstrates excellent diagnostic consistency and performance in clinical applications.
- Open Access
- 17 December 2024
- Published by Springer Nature in Research Square
Identification and Validation of a Novel Machine Learning Model for Predicting Severe Pelvic Endometriosis: A Retrospective Study
Background Severe endometriosis significantly impacts the quality of life, particularly in women of reproductive age. Though numerous studies have conducted predictive models with preoperative clinical data for endometriosis, most risk models focus on diagnosis rather than disease staging. This study aimed to explore potential factors for endometriosis severity and to develop a classification model to assess the accuracy of predicting the risk of severe endometriosis. Methods A total of 308 patients with endometriosis were retrospectively analyzed. The stage of endometriosis was classified according to the scoring system of the revised American Society for Reproductive Medicine (rASRM) system, through surgical visualization,which is the most widely used staging system globally. All patients underwent preoperative transabdominal and transvaginal ultrasound, based on four steps screening approach proposed by The International Deep Endometriosis Analysis (IDEA) consensus. We randomly divided these data into training and testing datasets at a ratio of 8:2. Least absolute shrinkage and selection operator (LASSO) was performed to identify the potential risk factors for severe endometriosis. Then, we used 7 machine learning(ML) models to construct the predictive models. The area under the receiver-operating-characteristics curve (AUC) and accuracy were used to evaluate and determine the most effective model. Finally, SHapley Additive exPlanations (SHAP) interpretation was calculated to evaluate each parameter's contribution to risk prediction. Results In this retrospective study, about 59.2% (183/308) of endometriosis patients were diagnosed with severe endometriosis. The predictors of severe endometriosis occurrence were found to be compliance of 18 factors such as the negative sliding sign, pelvic fluid, bilateral OE, serum CA125 level and severe dysmenorrhea according to LASSO. The random forest (RF) model performed best in discriminative ability among the 7 ML models. After reducing features according to feature importance rank, an explainable final RF model was established with 6 features. The final model could accurately predict severe endometriosis with the area under curve (AUC) of 0.744 and an accuracy of 0.667 in the test set. From the SHAP map, it was found that the negative sliding sign had the greatest impact on the diagnostic performance of the RF model. Conclusions We constructed a predictive model based on the ML model, and the RF model showed a better performance. we also provided a personalized risk assessment for the development of stage IV in endometriosis patients explained by SHAP. This can help clinicians to treat severe endometriosis.
- 17 December 2024
- Published by Springer Nature in Research Square
Open AccessIdentification and Validation of a Novel Machine Learning Model for Predicting Severe Pelvic Endometriosis: A Retrospective Study
Background Severe endometriosis significantly impacts the quality of life, particularly in women of reproductive age. Though numerous studies have conducted predictive models with preoperative clinical data for endometriosis, most risk models focus on diagnosis rather than disease staging. This study aimed to explore potential factors for endometriosis severity and to develop a classification model to assess the accuracy of predicting the risk of severe endometriosis. Methods A total of 308 patients with endometriosis were retrospectively analyzed. The stage of endometriosis was classified according to the scoring system of the revised American Society for Reproductive Medicine (rASRM) system, through surgical visualization,which is the most widely used staging system globally. All patients underwent preoperative transabdominal and transvaginal ultrasound, based on four steps screening approach proposed by The International Deep Endometriosis Analysis (IDEA) consensus. We randomly divided these data into training and testing datasets at a ratio of 8:2. Least absolute shrinkage and selection operator (LASSO) was performed to identify the potential risk factors for severe endometriosis. Then, we used 7 machine learning(ML) models to construct the predictive models. The area under the receiver-operating-characteristics curve (AUC) and accuracy were used to evaluate and determine the most effective model. Finally, SHapley Additive exPlanations (SHAP) interpretation was calculated to evaluate each parameter's contribution to risk prediction. Results In this retrospective study, about 59.2% (183/308) of endometriosis patients were diagnosed with severe endometriosis. The predictors of severe endometriosis occurrence were found to be compliance of 18 factors such as the negative sliding sign, pelvic fluid, bilateral OE, serum CA125 level and severe dysmenorrhea according to LASSO. The random forest (RF) model performed best in discriminative ability among the 7 ML models. After reducing features according to feature importance rank, an explainable final RF model was established with 6 features. The final model could accurately predict severe endometriosis with the area under curve (AUC) of 0.744 and an accuracy of 0.667 in the test set. From the SHAP map, it was found that the negative sliding sign had the greatest impact on the diagnostic performance of the RF model. Conclusions We constructed a predictive model based on the ML model, and the RF model showed a better performance. we also provided a personalized risk assessment for the development of stage IV in endometriosis patients explained by SHAP. This can help clinicians to treat severe endometriosis.
- Open Access
- 23 October 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-4
Ultrasonic diagnosis of hepatic ectopic pregnancy: a case report
- 23 October 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-4
Open AccessUltrasonic diagnosis of hepatic ectopic pregnancy: a case report
- 3 May 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (6) , 2117-2123
Screening value of lung ultrasound and pleural shear wave elastography in connective tissue disease–related interstitial lung disease: a preliminary study
Objective To explore the diagnostic value of lung ultrasound (LUS) and pleural shear wave elastography (SWE) for connective tissue disease–interstitial lung disease (CTD-ILD). Methods We selected 104 patients diagnosed with connective tissue disease (CTD) at our hospital. All patients underwent LUS, SWE, and high-resolution computed tomography (HRCT). With HRCT as the imaging gold standard for diagnosis, patients were categorized into CTD-ILD and CTD-non-ILD groups. We employed paired chi-square tests to compare the diagnostic differences between HRCT and LUS for ILD. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of pleural SWE for ILD. Correlation analysis was performed between pleural elasticity values and lung ultrasound scores. Results The sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of LUS for diagnosing CTD-ILD were 93.3%, 86.2%, 6.761, and 0.078, respectively. There was no statistically significant difference in the results between HRCT and LUS (P = 1.000), with a kappa value of 0.720 (P < 0.001). There was a statistically significant difference in the pleural elasticity in the bilateral lower back region between the case and control groups (P < 0.001). The area under the receiver operating characteristic (ROC) curve (AUC) for pleural SWE in diagnosing CTD-ILD was 0.685. In CTD-ILD patients, there was no significant correlation between pleural elasticity values and LUS scores (P > 0.05). Conclusion The LUS can serve as an important imaging method for screening for CTD-ILD and assessing the severity of the disease. However, pleural SWE has been shown to demonstrate lower diagnostic efficacy for CTD-ILD, and its ability to assess disease severity is limited. Key Points • The LUS can serve as an important imaging method for screening for CTD-ILD and assessing the severity of the disease. • Pleural SWE has been shown to demonstrate lower diagnostic efficacy for CTD-ILD, and its ability to assess disease severity is limited.
- 3 May 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (6) , 2117-2123
Screening value of lung ultrasound and pleural shear wave elastography in connective tissue disease–related interstitial lung disease: a preliminary study
Objective To explore the diagnostic value of lung ultrasound (LUS) and pleural shear wave elastography (SWE) for connective tissue disease–interstitial lung disease (CTD-ILD). Methods We selected 104 patients diagnosed with connective tissue disease (CTD) at our hospital. All patients underwent LUS, SWE, and high-resolution computed tomography (HRCT). With HRCT as the imaging gold standard for diagnosis, patients were categorized into CTD-ILD and CTD-non-ILD groups. We employed paired chi-square tests to compare the diagnostic differences between HRCT and LUS for ILD. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of pleural SWE for ILD. Correlation analysis was performed between pleural elasticity values and lung ultrasound scores. Results The sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of LUS for diagnosing CTD-ILD were 93.3%, 86.2%, 6.761, and 0.078, respectively. There was no statistically significant difference in the results between HRCT and LUS (P = 1.000), with a kappa value of 0.720 (P < 0.001). There was a statistically significant difference in the pleural elasticity in the bilateral lower back region between the case and control groups (P < 0.001). The area under the receiver operating characteristic (ROC) curve (AUC) for pleural SWE in diagnosing CTD-ILD was 0.685. In CTD-ILD patients, there was no significant correlation between pleural elasticity values and LUS scores (P > 0.05). Conclusion The LUS can serve as an important imaging method for screening for CTD-ILD and assessing the severity of the disease. However, pleural SWE has been shown to demonstrate lower diagnostic efficacy for CTD-ILD, and its ability to assess disease severity is limited. Key Points • The LUS can serve as an important imaging method for screening for CTD-ILD and assessing the severity of the disease. • Pleural SWE has been shown to demonstrate lower diagnostic efficacy for CTD-ILD, and its ability to assess disease severity is limited.